| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 693563 | Null | 0.0306776553926119 | 0.46103607 |
| NSC 698065 | Null | 0.0306776553926119 | -0.27918774 |
| NSC 699081 | Null | 0.0306776553926119 | 0.38211741 |
| NSC 703823 | 3-Hydroxy-16(4'-pyridylmethylene)-17-oxo-1,3,5(10)-estratriene | 0.0306776553926119 | 0.49817288 |
| NSC 707465 | 2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- | 0.0306776553926119 | 0.35577931 |
| NSC 708416 | Null | 0.0306776553926119 | 0.31302109 |
| NSC 728132 | 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3,4-dichlorobenzene | 0.0306776553926119 | 0.28410358 |
| NSC 732517 | Dasatinib | 0.0306776553926119 | -0.25561508 |
| NSC 732698 | 1-{4-[4-chloro-1-(2,4-dichlorobenzyl)-2,5-dioxo-2,5-dihydro- 1H-3-pyrrolylamino]phenylcarboxamido}-3-trifluoromethylbenze ne | 0.0306776553926119 | 0.33373434 |
| NSC 736079 | 4-[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-6-pyrrolidin-1-yl-1 ,3,5-triazin-2-ylamine | 0.0306776553926119 | 0.3354024 |